|
N.S. Besova, S.V. Khokhlova, V.A. Gorbunova
Herceptin In The Treatment Of Disseminated Her2-positive Gastric Cancer: A Clinical Case Of Successful Treatment Of Elderly Patient
|
№18 / 2012
|
|
L.G.Zhukova, M.R. Lichinitser
Adjuvant Therapy With Trastuzumab For Early-stage Breast Cancer: 12 Or 24 Months (based On Esmo Data, Vienna, October, 2012)
|
№18 / 2012
|
|
D.D. Sakayeva, R.I. Kunafina, E.V. Popova
Experience Of Use Of Trastuzumab In The Republic Of Bashkortostan
|
№8 / 2012
|
|
I.S. Bulavina, V.V. Petkau, D.D. Sakaeva, N.V. Strakhova, E.N. Gordeeva, T.V. Vinogradova
Experience Of Use Of Trastuzumab (herceptin) In Adjuvant Therapy For Breast Cancer In Sverdlovsk Region: First Results
|
№20 / 2011
|
|
T.Yu. Semiglazova, V.V. Semiglazov, L.V. Filatova, V.A. Chubenko, N.V. Brejnev, F.V. Moiseenko, D. Latipova, M.L. Gershanovich
Targeted Therapy After Progression Of Her-2-positive Breast Cancer
|
№17 / 2011
|
|
T.Yu Semiglazova, L.V. Filatova, D.Kh Latipova, M.L. Gershanovich
Target Therapy Her2-positive Breast Cancer With Brain Metastases: New Prospects For Treatment
|
№17 / 2010
|
|
V.F. Semiglazov, G.A. Dashian, V.V. Semiglazov, R.V. Dovskih, R.M. Paltuev
Treatment Of Operable And Relatively Operable Forms Of Breast Cancer
|
№18 / 2009
|
|
A.N. Lud, I.P. Ganshina
Bevacizumab (avastin) In The Treatment Of Patients With Breast Cancer
|
№18 / 2009
|
Русский
